Workflow
Danaher(DHR)
icon
Search documents
Danaher Corporation (DHR) Presents at BofA Securities 2024 Health Care Conference Call Transcript
2024-05-14 21:00
Sirius XM Holdings Inc. (SIRI) BofA Securities 2024 Health Care Conference Call May 14, 2024 1:40 PM ET Company Participants Rainer Blair - President and Chief Executive Officer Conference Call Participants Michael Ryskin - Bank of America Michael Ryskin Everyone will kick things off for our next session. My name is Mike Ryskin. I'm on the Bank of America Life Science Tools and Diagnostics teams and I'm thrilled to host Danaher and I'm joined by Rainer Blair, CEO. Rainer, thanks so much for coming. Rainer B ...
Danaher Corporation (DHR) Is a Trending Stock: Facts to Know Before Betting on It
Zacks Investment Research· 2024-05-08 14:02
Danaher (DHR) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.Shares of this industrial and medical device maker have returned -0.4% over the past month versus the Zacks S&P 500 composite's -0.2% change. The Zacks Diversified Operations industry, to which Danaher belongs, has gained 1.6% over this period. Now the key question is: Where could the stock be headed in ...
Danaher to Present at Bank of America Securities Healthcare Conference
PRNewsWire· 2024-05-07 20:45
WASHINGTON, May 7, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the at the Bank of America Securities Health Care Conference in Las Vegas, Nevada on Tuesday, May 14, 2024 at 10:40 a.m. PT. The event will be simultaneously webcast on www.danaher.com.ABOUT DANAHERDanaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human h ...
Curiox Biosystems and Beckman Coulter Life Sciences Announce a Partnership Combining C-FREE™ Technology with DURA Innovations for Hands-Free Washed Sample Preparation for Flow Cytometry
Prnewswire· 2024-05-03 13:06
WOBURN, Mass., May 3, 2024 /PRNewswire/ -- Curiox Biosystems Co. Ltd (Curiox), a leader in the innovation of life science research technologies, and Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, announce a strategic partnership to provide researchers with a one-stop solution for hands-free washed sample preparation for flow cytometry. See How it Works with Laminar Wash™ The agreement combines the Laminar flow-based gentle liquid exchange technology known as ...
The Forgotten Stock Advice That Delivers 170%+ Payout Growth
Forbes· 2024-05-01 13:15
Charts and calculatorCalculator and chartsgettyOne of the best ways to grab a dividend payer set to surge is a strategy you never hear about anymore: Pick up shares of a conglomerate.I know, I know. The word brings to mind “old school” companies like 3M (MMM)—which we discussed a couple weeks ago—and Honeywell International Honeywell International (HON).The deal on these companies is that they’re basically a collection of businesses that often have little overlap. They’re hated by Wall Street because they’r ...
What Should You Do With Danaher Stock At $250 After Q1 Beat?
Forbes· 2024-04-26 12:00
GERMANY - 2024/04/02: In this photo illustration, a Danaher Corporation logo seen displayed on a ... [+] tablet. (Photo Illustration by Igor Golovnov/SOPA Images/LightRocket via Getty Images)SOPA Images/LightRocket via Getty ImagesDanaher stock (NYSE: DHR), a conglomerate with products in life sciences, biotechnology, and diagnostics fields, recently posted its Q1 results that exceeded the street expectations. The company reported revenue of $5.8 billion and adjusted earnings of $1.92 per share, compared to ...
Danaher (DHR) Q1 Earnings Beat, Biotechnology Sales Dip Y/Y
Zacks Investment Research· 2024-04-23 16:31
Danaher Corporation’s (DHR) first-quarter 2024 adjusted earnings (excluding 47 cents from non-recurring items) of $1.92 per share surpassed the Zacks Consensus Estimate of $1.72. The bottom line declined 27.1% year over year.Danaher’s net sales of $5.8 billion outperformed the consensus estimate of $5.6 billion. However, the metric declined 2.5% year over year due to lower core sales in the Biotechnology segment.Organic sales in the quarter decreased 4%. Foreign-currency translations and acquisitions had a ...
Earnings Today: PulteGroup, Danaher Rally; JetBlue Dives
Investors Business Daily· 2024-04-23 15:33
Big earnings movers early Tuesday included GE Aerospace (GE), General Motors (GM) and UPS (UPS). PulteGroup (PHM), Danaher (DHR) and JetBlue (JBLU) were also making big moves on earnings today, on both good and bad news.X Earnings Today: PulteGroup Margins WidenHomebuilder PulteGroup popped higher in morning trade Tuesday. The Atlanta, Ga.-based builder reported EPS of $3.10, clobbering consensus views for $2.36. Revenue was $3.95 billion, above the $3.59 billion target. Its home sales gross margin increase ...
Danaher(DHR) - 2024 Q1 - Earnings Call Presentation
2024-04-23 14:39
Danaher Corporation First Quarter 2024 Earnings Release ...
Danaher(DHR) - 2024 Q1 - Earnings Call Transcript
2024-04-23 14:39
Danaher Corporation (NYSE:DHR) Q1 2024 Earnings Conference Call April 23, 2024 8:00 AM ET Company Participants John Bedford - VP of IR Rainer Blair - President & CEO Matthew McGrew - EVP & CFO Conference Call Participants Jack Meehan - Nephron Research Michael Ryskin - Bank of America Scott Davis - Melius Research Vijay Kumar - Evercore ISI Douglas Schenkel - Wolfe Research Daniel Leonard - UBS Rachel Vatnsdal - JPMorgan Operator Hello. My name is Todd, and I will be your conference facilitator this morning ...